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Mucinous Carcinoma with Extensive Signet Ring Cell Differentiation:  
A Case Report
Hye Min Kim · Eun Kyung Kim 
Ja Seung Koo
Department of Pathology, Yonsei University 
College of Medicine, Seoul, Korea
Breast cancers that present with mucin include mucinous carcinoma and carcinoma with signet 
ring cell differentiation. The former shows extracellular mucin and the latter shows abundant 
intracellular mucin. Here, we report a case of breast cancer showing both extracellular mucin and 
extensive signet ring cell differentiation due to abundant intracellular mucin. Unlike mucinous car-
cinoma, this case had the features of high-grade nuclear pleomorphism, high mitotic index, 
estrogen receptor negativity, progesterone receptor negativity, human epidermal growth factor 
receptor-2 positivity, and ductal type with positivity for E-cadherin. In a case with signet ring cell 
differentiation, differential diagnosis with metastatic signet ring cell carcinoma of the stomach and 
colon is essential. In this case, the presence of accompanied ductal carcinoma in situ component 
and mammaglobin and gross cystic disease fluid protein-15 positivity were findings that sug-
gested the breast as the origin.
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▒ CASE STUDY ▒
According to the World Health Organization (WHO) classi-
fication, breast cancers that could show mucinous differentiation 
include mucinous carcinoma and carcinoma with signet ring cell 
differentiation.1 Both tumors have a common feature in that they 
contain or secrete mucin; however, mucinous carcinoma exhibits 
tumor cells floating in the extracellular mucin,2 whereas in carci-
noma with signet ring cell differentiation, the tumor nucleus is 
pushed into a corner by abundant intracellular mucin.3 Carci-
noma with signet ring cell differentiation is reportedly difficult 
to define as a distinct entity, since prominent signet ring cell 
differentiation can appear in invasive lobular carcinoma, invasive 
carcinoma of no special type, and other special types in common.4 
Mucinous carcinoma usually shows estrogen receptor (ER) and 
progesterone receptor (PR) positivity and human epidermal 
growth factor receptor-2 (HER-2) negativity with relatively good 
prognosis,5,6 while carcinoma with signet ring cell differentia-
tion frequently expresses ER and PR,7 with an uncertain prog-
nosis.8
Here, we report a case of breast cancer secreting prominent 
extracellular mucin and showing distinct signet ring cell differ-
entiation due to abundant intracellular mucin.
CASE REPORT
A 64-year-old woman presented with nipple discharge from 
right breast for 3 months. On physical examination, a palpable 
mass was noted in the right breast without other remarkable 
findings. She had no remarkable medical history or familial his-
tory. Diagnostic mammogram revealed a 5.4-cm-sized mass with 
microcalcification in the palpable area in the right upper medial 
portion of the breast. In magnification view, the parenchymal 
distortion measured about 6.3 cm in maximal diameter includ-
ing grouped coarse heterogeneous calcification. In diagnostic 
ultrasound, a 3-cm-sized heterogeneous area including calcifica-
tion in the inner part was observed 3 cm from the nipple in the 
right upper medial 2 o’clock direction and five core needle biopsies 
were performed. The pathologic diagnosis of biopsy was ductal 
carcinoma in situ (DCIS) with a suspicious area of invasion 
showing mucinous differentiation. Breast magnetic resonance 
imaging showed right nipple retraction without pathologic 
lymph node, and skeletal metastasis was not observed in whole 
body bone scan. The patient underwent total mastectomy and 
sentinel lymph node dissection of the right breast.
The surgical specimen was sent to the Department of Pathol-
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ogy. On gross examination, the cut surface revealed a gelatinous 
gray white mass (2.2 × 2.0 cm). On histologic examination, the 
tumor with expanding margin was observed in the low-power 
view (Fig. 1A). The tumor cell clusters were floating in the 
mucin pool and the cell density was higher in the periphery 
than in the center (Fig. 1A). In the high-power view, the tumor 
cell cluster floating in the mucin pool showed nuclear atypia 
suitable for nuclear grade 3 and the mitotic count was 14 in 10 
high power fields. Many tumor cells were seen as signet ring 
cells with the tumor nucleus pushed into a corner by abundant 
intracellular mucin (Fig. 1B). DCIS was observed in the pe-
riphery of the expanding invasive nodule, comprising 60% of 
invasive tumor area (Fig. 1C). The DCIS component showed a 
significantly high nuclear grade and signet ring cell differentia-
tion, but extracellular mucin was not observed (Fig. 1D). Serial 
immunohistochemical staining results showed that tumor cells 
were negative for ER (Fig. 1E) and PR (Fig. 1F) and positive 
for HER-2 (3+) (Fig. 1G), with a Ki-67 labeling index of about 
30%. In addition, tumor cells were positive for mammaglobin 
(Fig. 1H), gross cystic disease fluid protein-15 (GCDFP-15) 
(Fig. 1I), E-cadherin, and MUC-1, and tumor mucin was posi-
tive for Alcian blue and mucicarmine. A total of 12 axillary 
lymph nodes were evaluated, but no metastasis was noted. The 
patient has been followed on an outpatient basis after surgery 
and to date, there is no evidence of recurrence or metastasis.
DISCUSSION
Representative breast cancers that secrete mucin are muci-
nous carcinoma and carcinoma with signet ring cell differentia-
tion according to WHO classification.1 In mucinous carcinoma, 
mucin appears as extracellular mucin,2 whereas in carcinoma 
with signet ring cell differentiation, mucin is shown as abundant 
intracellular mucin.3 However, the case reported here had the 
typical findings of both extracellular mucin and extensive sig-
net ring cell differentiation due to abundant intracellular mucin. 
In addition, this case was different from typical mucinous carci-
noma due to the existence of the following features: (1) high-
Fig. 1. Histologic features and biomarker status in mucinous carcinoma with extensive signet ring cell differentiation. (A) In the low-power 
view, a tumor with an expanding margin is observed. Tumor cell clusters floating in the mucin pool are shown and the cell density is higher in 
the periphery than in the center. (B) In the high-power view, tumor cell cluster floating in the mucin pool shows dysplasia suitable for the 
nuclear grade 3. Many tumor cells are seen as signet ring cell with the nucleus pushed into the corner by abundant intracellular mucin. (C) 
Ductal carcinoma in situ (DCIS) is observed in the periphery of the expanding invasive nodule. (D) The DCIS component shows significantly 
high nuclear grade and signet ring cell differentiation.                                                                                            (Continued to the next page)
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grade nuclear pleomorphism, (2) high mitotic index, and (3) ER 
negativity, PR negativity, and HER-2 positivity. Carcinoma with 
signet ring cell differentiation has been reported to appear mainly 
in lobular carcinoma.9 However, we suggest that this case is ductal 
type due to the positivity of E-cadherin. In the case of carcinoma 
with signet ring cell differentiation, hormone receptors are re-
ported to be positive;7 however, in this case, there was a differ-
ence in that the ER and PR immunohistochemical staining results 
were negative. In previous studies of carcinoma with signet ring 
cell differentiation, some reported that mucinous carcinoma is 
accompanied by signet ring cell component, which is a similar 
finding with this case. However, the proportion of signet ring 
cell component in mucinous carcinoma was reported to be 8%–
17%, which shows significant difference with this case in the 
amount of signet ring cell component.4 Previously published 
case reports that are most similar to this case include the report 
by Leung et al.,10 which showed very similar histologic feature 
with this case. Furthermore, Kuroda et al.11 reported a case of 
invasive ductal carcinoma of breast with signet ring cell and 
mucinous carcinoma components, which is a similar finding to 
that in this report. To the best of our knowledge, the case reported 
here is the first case reported in Korea.
In such a case with signet ring cell differentiation, the most 
important differential diagnosis is metastatic signet ring cell car-
cinoma. In signet ring cell carcinoma of the stomach and colon 
extracellular mucin and signet ring cell differentiation due to 
abundant intracellular mucin are frequently observed. The pres-
ence of accompanied DCIS component and mammaglobin and 
GCDFP-15 positivity in this case suggest breast as the origin. 
The immunohistochemical markers widely used to help differ-
entiate between signet ring cell carcinoma of the stomach and 
colon and signet ring cell carcinoma of the breast are CDX2, 
cytokeratin 20, MUC-1, and ER.12
The case reported here shows both extracellular mucin and 
extensive signet ring cell differentiation due to abundant intra-
cellular mucin. Notably, this finding does not appear in separate 
regions in the tumor, but as a pattern of floating signet ring cell 
in a mucin pool. Therefore, we speculate that this finding is not 
a result of a mixed form of mucinous carcinoma and carcinoma 
with signet ring cell differentiation, but rather is signet ring cell 
differentiation in mucinous carcinoma cells. We report this case 
because it has the features of high-grade nuclear pleomorphism, 
Fig. 1. (Continued from the previous page) Mucinous carcinoma cells are negative for estrogen receptor (E) and progesterone receptor (F) 
and positive for human epidermal growth factor receptor-2 (3+) (G). Mucinous carcinoma cells are positive for mammaglobin (H) and gross 
cystic disease fluid protein-15 (I).
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high mitotic index, ER negativity, PR negativity, and HER-2 
positivity, which differ from typical mucinous carcinoma.
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